Guizhou Bailing's Three Products Chosen for China's Centralized Procurement for Traditional Medicine
Guizhou Bailing Group Pharmaceutical (SHE:002424) said three of its products were selected for China's centralized procurement of traditional Chinese medicine, according to a Shenzhen bourse filing on Monday.The products chosen were Yindan Xinnaotong Soft Capsules, Hugan Tablets, and Qiangli Pipa Syrup.The Chinese pharmaceutical company's shares jumped 5% at the close.